SCHEMBL4554424

SCHEMBL4554424

CCOC(=O)[C@]1(Br)CCCCC1=O

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 5/20 0.41
CYP3A4 P08684 3/20 0.41
POLB P06746 1/20 0.38
ALDH1A1 P00352 4/20 0.38
CYP2C9 P11712 1/20 0.38
TSHR P16473 1/20 0.38
MEN1 O00255 2/20 0.37
CYP2D6 P10635 2/20 0.37
KMT2A Q03164 2/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
ATM Q13315 1/20 0.36
MAPT P10636 2/20 0.35
KDM4E B2RXH2 4/20 0.34
OPRM1 P35372 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
HPGD P15428 1/20 0.34
HSD17B10 Q99714 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13009913 1.00 CYP2C19 (0.41) CYP2C19CYP3A4POLBALDH1A1CYP2C9
SCHEMBL28255942 0.95 CYP2C19 (0.45) CYP2C19CYP3A4POLBALDH1A1CYP2C9
SCHEMBL4053114 0.81 NPSR1 (0.40) CYP2C19CYP3A4CYP2C9TSHRMAPT
SCHEMBL1577155 0.79 ATM (0.45) CYP2C19CYP3A4POLBALDH1A1CYP2C9
SCHEMBL4622471 0.79 NPSR1 (0.39) CYP2C19CYP3A4ALDH1A1CYP2C9TSHR
SCHEMBL16391277 0.78 CYP2C19 (0.40) CYP2C19CYP3A4POLBALDH1A1CYP2C9
SCHEMBL875700 0.78 CYP2C19 (0.40) CYP2C19CYP3A4POLBALDH1A1CYP2C9
SCHEMBL21244980 0.78 CYP2C19 (0.38) CYP2C19CYP3A4POLBALDH1A1CYP2C9
SCHEMBL7928918 0.77 CYP2C19 (0.39) CYP2C19CYP3A4POLBALDH1A1CYP2C9
SCHEMBL7722193 0.77 ALDH1A1 (0.39) CYP2C19CYP3A4POLBALDH1A1CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2134683-A2 NOVEL INHIBITORS HEPATITIS C VIRUS REPLICATION Intermune, Inc. (US) 2009-12-23 EP disclosed
WO-2008100867-A2 NOVEL INHIBITORS HEPATITIS C VIRUS REPLICATION INTERMUNE, INC. (US) 2008-08-21 WO disclosed